Stability and compatibility of Teicoplanin in parenteral nutrition solutions used in pediatrics

Clinical Nutrition

Volumn 18, Issue 3, 1999, Pages 159-165

  Tounian, P ^a   Jehl, F ^b   Pauliat, S ^a   Morgant, G ^a   Ghirardi, L ^c   Selva, M A ^a   Fontaine, J L ^a   Aymard, P ^a   Girardet, J P ^a  

^a ARMAND TROUSSEAU HOSPITAL   (France)

^b Institute of Bacteriology   (France)

^c Information et Communication Consultants   (France)

Author keywords

Antibiotics; Central venous catheter; Parenteral nutrition; Sepsis; Stability; Teicoplanin

Indexed keywords

TEICOPLANIN;

ARTICLE; CATHETER INFECTION; DIFFUSION; DRUG STABILITY; DRUG STORAGE; ENVIRONMENTAL TEMPERATURE; FILTRATION; MEMBRANE FILTER; OSMOLALITY; PARENTERAL NUTRITION; PEDIATRICS; PH; SOLUTION AND SOLUBILITY; TEMPERATURE;

EID: 0032805389     PISSN: 02615614     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0261-5614(99)80006-5     Document Type: Article

References (22)

1. Goulet O, Larchet M, Gaillard J L et al. Catheter related sepsis during long-term parenteral nutrition in pediatric gastroenterology patients: a study of 186 consecutive central venous catheters. Clin Nutr 1990; 9: 73-78
2. Schmidt-Sommerfeld E, Snyder G, Rossi T M, Lebenthal E. Catheter-related complications in 35 children and adolescents with gastrointestinal disease on home parenteral nutrition. JPEN 1990; 14: 148-151
3. Nahata M C, King D R, Powell D A, Marx S M, Ginn-Pease M E. Management of catheter-related infections in pediatric patients. JPEN 1988; 12: 58-59
4. Gaillard J L, Merlino R, Pajot N et al. Conventional and nonconventional modes of vancomycin administration to decontaminate the internal surface of catheters colonized with coagulase-negative staphylococci. JPEN 1990; 14: 593-597
5. Richet H, Hubert B, Nitenberg G et al. Prospective multicenter study of vascular-catheter-related complications and risk factors for positive central-catheter cultures in intensive care unit patients. J Clin Microbiol 1990; 28: 2520-2525
6. Smith S R, Cheesbrough J, Spearing R, Davies J M. Randomized prospective study comparing vancomycin with teicoplanin in the treatment of infections associated with Hickman catheters. Antimicrob Agents Chemother 1989; 33: 1193-1197
7. Ley B E, Jalil N, McIntosh J et al. Bolus or infusion teicoplanin for intravascular catheter associated infections in immunocompromised patients? J Antimicrob Chemother 1996; 38: 1091-1095
8. Fox A S, Boyer K M, Sweeney H M. Antibiotic stability in a pediatric parenteral alimentation solution. J Pediatr 1988; 112: 813-817
9. Schilling C G, Watson D M, McCoy H G, Uden D L. Stability and delivery of vancomycin hydrochloride when admixed in a total parenteral nutrition solution. JPEN 1989; 13: 63-64
10. Yao J D C, Arkin C F, Karchmer A W. Vancomycin stability in heparin and total parenteral nutrition solutions: novel approach to therapy of central venous catheter-related infections. JPEN 1992; 16: 268-274
11. Streng W H, Brake N W. Dextrose adduct formation in aqueous teicoplanin solutions. Pharmaceutical Res 1989; 6: 1032-1038
12. Mawhinney W M, Adair C G, Gorman S P, McClurg B. Long-term stability of teicoplanin in dialysis fluid: implications for the home-treatment of CAPD peritonitis. Int J Pharm Pract 1991; 1: 90-93
13. Kennedy H F, Seal D V. Influence of inoculum, medium and serum on the in-vitro susceptibility of coagulase-negative staphylococci to teicoplanin and vancomycin. J Antimicrob Chemother 1996; 37: 1103-1109
14. Davey P G, Williams A H. A review of the safety profile of teicoplanin. J Antimicrob Chemother 1991; 27(suppl B): 69-73
15. Krcmery V, Trupl J, Drgona L, Lacka J, Kukuckova, Oravcova E. Nosocomial bacteremia due to vancomycin-resistant Staphylococcus epidermidis in four patients with cancer, neutropenia, and previous treatment with vancomycin. Eur J Clin Microbiol Infect Dis 1996; 15: 259-261
16. Lemerle S, de La Rocque F, Lamy R et al. Teicoplanin in combination therapy for febrile episodes in neutropenic and nonneutropenic paediatric patients. J Antimicrob Chemother 1988; 21(suppl A): 113-116
17. Jehl F, Monteil H, Tarral A. HPLC quantitation of the six main components of teicoplanin in biological fluids. J Antimicrob Chemother 1988; 21(suppl A): 53-59
18. Brogden R N, Peters D H. Teicoplanin. A reappraisal of its antimicrobial activity, pharmacokinetic properties and therapeutic efficacy. Drugs 1994; 47: 823-854
19. Perry M, Khalidi N, Sanders C A. Stability of penicillins in total parenteral nutrient solution. Am J Hosp Pharm 1987; 4: 1625-1628
20. Zaccardelli D S, Krcmarik C S, Wolk R, Khalidi N. Stability of imipenem and cilastatin sodium in total parenteral nutrient solution. JPEN 1990; 14: 306-309
21. Barnett M I, Cosslett A G, Duffield J R, Evans D A, Hall S B, Williams D R. Parenteral nutrition. Pharmaceutical problems of compatibility and stability. Drug Safety 1990; 5(suppl 1): 101-106
22. Anglade P, Corriol O, Ricour C, Postaire E. Variations de biodisponibilité des constituants au sein des mélanges de nutrition parentrale, analyse de la formation de complexes cystine-zinc. Nutr Clin Metabol 1990; 4: 167-171